← Back to Search

Non-elevated depressed mood for Alcoholism

Phase 4
Waitlist Available
Led By Robert Leeman, PhD
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60 days (from phone screening to follow-up retest)
Awards & highlights

Study Summary

This trial is testing whether videotaping people while they drink can help identify those with alcohol use disorder. There are 4 phases: pre-screening, in-person screening, the drinking session, and follow-up.

Eligible Conditions
  • Alcoholism

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60 days (from phone screening to follow-up retest)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 60 days (from phone screening to follow-up retest) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Potential of Alcohol Topography as Indicator of AUD

Trial Design

4Treatment groups
Active Control
Group I: Non-elevated depressed moodActive Control2 Interventions
Lower score on Patient Health Questionnaire
Group II: Social Drinking statusActive Control2 Interventions
The social drinker group will be those who consume alcohol regularly but with infrequent heavy drinking days.
Group III: Heavy drinker statusActive Control2 Interventions
The heavy drinker group will be those who consume alcohol regularly with frequent heavy drinking days.
Group IV: Elevated Mental StatusActive Control2 Interventions
Elevated score on Patient Health Questionnaire

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor
1,340 Previous Clinical Trials
715,686 Total Patients Enrolled
7 Trials studying Alcoholism
421 Patients Enrolled for Alcoholism
Robert Leeman, PhDPrincipal InvestigatorUniversity of Florida
3 Previous Clinical Trials
136 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has the FDA accepted Social Drinking status as a legitimate treatment?

"Power's team rated social drinking status as a 3 on our rating scale due to this being an approved Phase 4 trial, suggesting that the efficacy and safety of this treatment has been well-established."

Answered by AI

Does the eligibility criteria of this medical trial include individuals under 55 years old?

"Participants of this trial must be above the legal drinking age and not over 55 years old."

Answered by AI

Is there an opportunity to participate in this research project?

"This medical research requires 44 individuals, aged 21-55 years old, who indulge in alcohol consumption. Other essential prerequisites include English literacy and the capacity to complete study assessments; good health condition with reported alcohol use over the last month; disinterest in current substance abuse treatments; and a willingness to provide urine drug testing."

Answered by AI

Is the enrollment period for this research still open?

"According to the details on clinicaltrials.gov, this trial is not presently in need of applicants. This investigation was initially published on October 12th 2017 and most recently updated June 10th 2022. Though there are no openings at present, 363 other studies are open for enrollment now."

Answered by AI
~1 spots leftby Apr 2025